Drug receives priority review for HCLApril 5, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Agent exhibits activity in leukemias, MDSApril 4, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
FDA approves blinatumomab to treat MRD+ BCP-ALLApril 3, 2018Leukemia, Myelodysplasia, TransplantationPharmacyALL
Drug receives orphan designation for AMLApril 3, 2018Leukemia, Myelodysplasia, TransplantationPharmacyAML
Disease, genetics contribute to neurocognitive decline in ALLMarch 30, 2018Leukemia, Myelodysplasia, TransplantationPediatricsALL
UCART19 can bridge to transplant in adultsMarch 29, 2018Leukemia, Myelodysplasia, TransplantationTransplantationALL
CHMP supports expanded approval for fosaprepitantMarch 29, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated Issues
Phase 1 results with UCART19 in kidsMarch 28, 2018Leukemia, Myelodysplasia, TransplantationPediatricsTransplantationALL
ICER assesses value of CAR T-cell therapiesMarch 27, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves nilotinib for kids with CMLMarch 23, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Health Canada approves SC rituximab for CLLMarch 23, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyAggressive Lymphomas
Ponatinib efficacy maintained despite dose reductionsMarch 23, 2018Leukemia, Myelodysplasia, TransplantationCML
Manufactured graft deemed safe in blood cancer patientsMarch 21, 2018AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLALLMyelodysplastic Syndrome
Metabolic changes in T cells may limit CAR potential in kidsMarch 19, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLAggressive Lymphomas
